Intervention Review

Pneumococcal vaccines for sickle cell disease

  1. E Graham Davies1,*,
  2. Ceri Hirst2,
  3. Richard Lottenberg3,
  4. Nancy Dower4

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 26 JAN 2004

Assessed as up-to-date: 9 DEC 2011

DOI: 10.1002/14651858.CD003885.pub2

How to Cite

Davies EG, Hirst C, Lottenberg R, Dower N. Pneumococcal vaccines for sickle cell disease. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003885. DOI: 10.1002/14651858.CD003885.pub2.

Author Information

  1. 1

    Great Ormond Street Hospital, Host Defence Unit, London, UK

  2. 2

    AstraZeneca, Alderley Park, Cheshire, UK

  3. 3

    University of Florida College of Medicine, Division of Hematology/Oncology, Florida, USA

  4. 4

    Faculty of Medicine, Department of Pediatrics, Edmonton, Alberta, Canada

*E Graham Davies, Host Defence Unit, Great Ormond Street Hospital, Great Ormond Street, London, WC1N 3JH, UK. davieg1@gosh.nhs.uk.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 26 JAN 2004

SEARCH

  1. Current Version

    Pneumococcal vaccines for sickle cell disease

    E Graham Davies, Ceri Hirst, Richard Lottenberg and Nancy Dower

    Article first published online: 26 JAN 2004 | DOI: 10.1002/14651858.CD003885.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Pneumococcal vaccines for sickle cell disease

    EG Davies, R Lottenberg and N Dower

    Article first published online: 27 JUN 2002 | DOI: 10.1002/14651858.CD003885